Tech Company Financing Transactions
Ablative Solutions Funding Round
BioStar Ventures, Michigan Accelerator Fund and private investors participated in a $9.6 million venture round for Ablative Solutions. The round was announced on 1/8/2014.
Transaction Overview
Company Name
Announced On
1/8/2014
Transaction Type
Venture Equity
Amount
$9,575,077
Round
Undisclosed
Investors
BioStar Ventures (Lead Investor) (Steven Almany)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6203 San Ignacio Ave. 110
San Jose, CA 95119
USA
San Jose, CA 95119
USA
Phone
Website
Email Address
Overview
Ablative Solutions is a medical device firm thatoffers an alternative to surgical renal denervation for treating hypertension.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Fischell
Chief Executive Officer
Kate Rumrill
Chief Medical Officer
Timothy Fischell
VP - Bus. Development
Thomas Moore
VP - Finance
Lisa Mastromattei
VP - R & D
Darrin Kent
VP - Regulatory Affairs
Sonia Charrier
VP - Regulatory Affairs
Nicole Haratani
Browse more venture capital transactions:
Prev: 1/8/2014: Glooko venture capital transaction
Next: 1/8/2014: Medialets venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs